APA (7th ed.) Citation

Mendoza, M. A., Bhaimia, E., Alkhateeb, H. B., Razonable, R. R., & Thoendel, M. (2024). Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis? Transplant Infectious Disease, 26(6), 1. https://doi.org/10.1111/tid.14377

Chicago Style (17th ed.) Citation

Mendoza, Maria Alejandra, Eric Bhaimia, Hassan B. Alkhateeb, Raymund R. Razonable, and Matthew Thoendel. "Which Allogeneic Hematopoietic Cell Transplant Recipients Have an Increased Risk for Delayed‐onset Clinically Significant Cytomegalovirus Infection After Letermovir Prophylaxis?" Transplant Infectious Disease 26, no. 6 (2024): 1. https://doi.org/10.1111/tid.14377.

MLA (9th ed.) Citation

Mendoza, Maria Alejandra, et al. "Which Allogeneic Hematopoietic Cell Transplant Recipients Have an Increased Risk for Delayed‐onset Clinically Significant Cytomegalovirus Infection After Letermovir Prophylaxis?" Transplant Infectious Disease, vol. 26, no. 6, 2024, p. 1, https://doi.org/10.1111/tid.14377.